Telesis Bio, Inc. (TBIO)

Telesis Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.72	1.57	30.42	82.81	13.46	29.14
Short-Term Investments	0.79	17.59	13.16	-	-	-
Cash & Short-Term Investments	4.51	19.16	43.58	82.81	13.46	29.14
Cash Growth	-89.11%	-56.04%	-47.37%	515.06%	-53.80%	-
Receivables	1.26	5.99	5.85	3.67	2.27	1.49
Inventory	1.1	4.03	2.2	2.37	0.6	0.71
Prepaid Expenses	1.1	1.01	3.29	4.35	0.85	0.09
Restricted Cash	0.1	0.18	0.18	-	-	-
Total Current Assets	8.12	30.35	55.09	93.18	17.18	31.43
Property, Plant & Equipment	11.99	34.52	8.52	5.74	3.78	0.89
Goodwill	3.5	3.5	14.89	14.33	3.5	3.5
Other Intangible Assets	0.64	1.37	1.88	2.4	2.33	2.86
Other Long-Term Assets	0.49	0.68	0.98	0.61	0.08	0.08
Total Assets	24.74	70.41	81.36	116.26	26.86	38.76

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	1.49	3.28	1.3	2.5	1.19	0.61
Accrued Expenses	1.93	2.65	7.24	4.85	1.69	0.89
Current Portion of Long-Term Debt	-	-	-	0.6	1.33	-
Current Portion of Leases	2.21	1.82	0.64	1.24	0.78	0.11
Current Unearned Revenue	0.26	0.34	3.96	0.21	0.61	0.11
Other Current Liabilities	0.74	0.09	0.37	0.34	0.02	-
Total Current Liabilities	6.63	8.18	13.5	9.73	5.63	1.72
Long-Term Debt	5.84	5.27	19.65	14.09	3.35	4.47
Long-Term Leases	8.25	27.29	1.14	1.39	2.86	0.19
Long-Term Unearned Revenue	0.15	0.1	0.14	0.15	0.04	0.03
Other Long-Term Liabilities	-	0.04	0.37	0.11	1.53	0.94
Total Liabilities	20.86	40.87	34.8	25.47	13.41	7.35

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	-	0.01	0.01	0.01	0	0
Additional Paid-In Capital	162.11	161.7	160.3	156.05	0.85	0.8
Retained Earnings	-189.33	-161.47	-113.74	-65.27	-26.31	-8.3
Comprehensive Income & Other	-0.01	-	-0	-	-	-
Total Common Equity	-27.22	0.24	46.57	90.78	-25.46	-7.5
Shareholders' Equity	3.87	29.54	46.57	90.78	13.46	31.41
Total Liabilities & Equity	24.74	70.41	81.36	116.26	26.86	38.76

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	16.29	34.38	21.43	17.32	8.33	4.77
Net Cash (Debt)	-11.78	-15.22	22.15	65.48	5.14	24.38
Net Cash Growth	-	-	-66.17%	1174.75%	-78.93%	-
Net Cash Per Share	-6.89	-9.18	13.53	64.68	18.49	87.75
Filing Date Shares Outstanding	1.78	1.67	1.65	1.63	0.28	0.28
Total Common Shares Outstanding	1.77	1.67	1.65	1.63	0.28	0.28
Working Capital	1.49	22.17	41.59	83.45	11.56	29.71
Book Value Per Share	-15.35	0.14	28.27	55.74	-91.21	-27.01
Tangible Book Value	-31.36	-4.63	29.8	74.06	-31.28	-13.86
Tangible Book Value Per Share	-17.69	-2.77	18.09	45.47	-112.07	-49.90
Machinery	7	9.86	7.24	2.62	1.32	1.25
Construction In Progress	0.06	0.59	1.5	1.54	0.1	-
Leasehold Improvements	0.12	0.33	0.06	0.1	0.03	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error